2. Gene
  3. C2 - complement C2 Gene

C2 - complement C2 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

基因 ID: 24231 | 基因类型: protein coding

关于 C2

功能概要

Predicted to enable serine-type endopeptidase activity. Involved in response to nutrient. Predicted to be located in extracellular region. Human ortholog(s) of this gene implicated in Alzheimer's disease; age related macular degeneration 14; Complement Component 2 deficiency; macular degeneration; and psoriasis. Orthologous to human C2 (complement C2). [provided by Alliance of Genome Resources, Apr 2022]

C2 基因产物(1)

mRNA Protein Name
NM_172222.2 NP_757376.2 complement C2 precursor
基因本体论
  • 分子功能
  • 生物过程
分子功能 GO 注释 逻辑证据 参考文献 来源
enables protein binding IPI
IPI: 通过物理相互作用推断
15060079 RGD
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in response to nutrient IEP
IEP: 通过表达模式推断
6776243 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

complement C2

complement component 2

相关产品

Approval
生物活性分子 (6)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B0581 Dexrazoxane 99.88% 是
HY-117974 Durlobactam sodium Inhibitor 99.62% 否
HY-14544 Quetiapine 99.93% 是
HY-19806A Ceftolozane sulfate Inhibitor 99.69% 否
HY-B0031 Quetiapine hemifumarate 99.96% 是
HY-B1915 Micronomicin Inhibitor 99.92% 否
Clinical Phase
生物活性分子 (5)
目录号 产品名 作用方式
纯度 Phase
HY-N0379 D-Mannose ≥98.0% Phase 4
HY-113071A Mevalonic acid lithium salt 99.80% Phase 3
HY-W654136 2'-Deoxycytidine-2'-13C / Phase 3
HY-W654098 Cefazolin-13C2,15N sodium Inhibitor / Phase 2
HY-113697 Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD 99.77% Phase 1
抗体抑制剂 (3)
目录号 产品名 作用方式
纯度 Phase
HY-P990091 Riliprubart Inhibitor 99.90% Phase 3
HY-P990025 Empasiprubart 97.93% Phase 3
HY-P99163 Tilavonemab Inhibitor 99.59% Phase 2
Pre-clinical Phase
生物活性分子 (1007)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-N0155 Nobiletin 99.79% 否
HY-N0376 Liquiritin 99.99% 否
HY-W021401 Amino-PEG3-C2-Azido 99.67% 否
HY-140213 Azido-PEG2-C2-amine 99.85% 否
HY-130109 N3-PEG4-C2-NHS ester 98.94% 否
HY-40171 NH2-C2-NH-Boc 99.97% 否
HY-W007596 Tris(2-phenylpyridinato-C2,N)iridium(III) 99.76% 否
HY-101180 C2 Ceramide 99.85% 否
HY-W008474 Boc-NH-PEG2-C2-NH2 99.38% 否
HY-128834 N3-PEG4-C2-NH2 ≥98.0% 否
HY-42776 NH2-PEG3-C2-NH-Boc 99.88% 否
HY-100594 EUK-134 Inhibitor 98.27% 否
HY-130653 Azido-PEG4-C2-acid ≥98.0% 否
HY-12315 N-Oxalylglycine Inhibitor 99.18% 否
HY-140452 Azido-PEG2-C2-acid ≥98.0% 否
HY-126526 N3-PEG2-C2-NHS ester ≥98.0% 否
HY-150795 SY-LB-35 99.54% 否
HY-140941 Biotin-PEG2-C2-iodoacetamide 98.23% 否
HY-130485 Bromo-PEG2-C2-azide 98.70% 否
HY-W015088 Amino-PEG3-C2-Amine 99.78% 否
HY-W015913S Sodium 2-oxopropanoate-13C3 Inhibitor 99.7% 否
HY-126528 N3-PEG3-C2-NHS ester 99.94% 否
HY-137320 diABZI-C2-NH2 Agonist 96.09% 否
HY-135804 NH2-PEG3-C2-Boc ≥97.0% 否
HY-150644 S07-2010 Inhibitor 98.35% 否
HY-42149 NH2-PEG2-C2-Boc ≥98.0% 否
HY-112821 IBS008738 98.22% 否
HY-N0602 Ginsenoside Rg2 Inhibitor 98.11% 否
HY-W022240 NH2-PEG5-C2-NH-Boc ≥95.0% 否
HY-W011235 Norfluoxetine hydrochloride Inhibitor 99.58% 否
HY-107452 SLF-amido-C2-COOH 99.63% 否
HY-156406 PITCOIN4 Inhibitor 99.97% 否
HY-130549 Acid-PEG3-C2-Boc ≥97.0% 否
HY-W092043 TLR4-IN-C34-C2-COOH Inhibitor 99.94% 否
HY-140009 Azido-PEG1-C2-acid ≥98.0% 否
HY-D0187S L-Glutathione reduced-13C2,15N Inhibitor 99.90% 否
HY-126520 N3-C2-NHS ester 99.77% 否
HY-Y0966S3 Glycine-13C2 99.10% 否
HY-119678 Fortunellin Activator 96.51% 否
HY-147007 β-catenin-IN-3 Inhibitor 96.58% 否
HY-124569 NAB-14 Antagonist 98.26% 否
HY-112820 Chlorantraniliprole 98.06% 否
HY-162809 XMU-MP-9 99.12% 否
HY-N4150 Quercetagitrin Inhibitor 98.34% 否
HY-125843 Pomalidomide-PEG1-C2-N3 99.63% 否
HY-147025 (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine 99.06% 否
HY-N0322S5 Cholesterol-13C2 Agonist 99.76% 否
HY-N1517 Ganoderic acid C2 99.72% 否
HY-W040168 Amino-PEG2-C2-acid 99.72% 否
HY-128845 PROTAC CRBN Degrader-1 Degrader 99.84% 否
HY-141364 Bromo-PEG1-C2-Boc 98.58% 否
HY-163084 HJ445A 98.31% 否
HY-B0351S1 Taurine-13C2 Inducer 99.0% 否
HY-112599B Pomalidomide-PEG4-C2-NH2 hydrochloride 97.01% 否
HY-112452 SU11652 99.06% 否
HY-130436 Acid-C2-PEG4-C2-NHS ester ≥98.0% 否
HY-22335 Amino-PEG4-C2-amine ≥98.0% 否
HY-B0351S2 Taurine-13C2,15N Inducer 98.60% 否
HY-108307 Micronomicin sulfate Inhibitor 99.96% 否
HY-140480 Acid-PEG2-C2-Boc ≥98.0% 否
HY-140585 N-DBCO-N-bis(PEG2-C2-NHS ester) ≥96.0% 否
HY-129703B Thalidomide-PEG2-C2-NH2 hydrochloride Inducer 99.93% 否
HY-128846A Pomalidomide-C2-NH2 hydrochloride 99.46% 否
HY-130483 Br-PEG3-C2-Boc ≥97.0% 否
HY-140127 Azide-C2-SS-C2-biotin 99.84% 否
HY-141365 Bromo-PEG2-C2-Boc ≥97.0% 否
HY-148896 (S,R,S)-AHPC-C2-PEG3-BCN 99.22% 否
HY-42151 Mal-amido-PEG2-C2-acid 99.80% 否
HY-N0543S Allantoin-13C2,15N4 99.90% 否
HY-W040165 Amino-PEG3-C2-acid 99.94% 否
HY-Y0966S2 Glycine-2-13C 99.3% 否
HY-114324 PROTAC PARP1 degrader Inhibitor 99.74% 否
HY-101159 Mal-amido-PEG8-C2-acid 99.04% 否
HY-124648 SMN-C2 98.85% 否
HY-164367 Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT 98.19% 否
HY-W010098S1 Terephthalic acid-13C2 99.60% 否
HY-W017970 Boc-C2-NH2 99.78% 否
HY-Y0966S6 Glycine-13C2,15N ≥99.0% 否
HY-W008567 N-Deschlorobenzoyl indomethacin ≥95.0% 否
HY-W021448S1 Glycocyamine-15N,13C2 97.40% 否
HY-168016 PROTAC YAP degrader-1 99.77% 否
HY-B0228S10 (R)-3-Hydroxybutanoic acid-13C2 sodium ≥98.0% 否
HY-23167 Acid-PEG4-C2-Boc 98.29% 否
HY-P10655 Caloxin 1C2 Inhibitor 98.86% 否
HY-W039168 Bromo-PEG3-C2-acid ≥97.0% 否
HY-Y0262S1 Oxalic acid-13C2 99.45% 否
HY-126688 Mal-C2-Gly3-EDA-PNU-159682 93.43% 否
HY-130101 Ald-Ph-amido-PEG4-C2-NHS ester 98.12% 否
HY-130315 Br-PEG4-C2-Boc ≥98.0% 否
HY-130396 DBCO-PEG4-C2-acid 99.22% 否
HY-141362 Bromo-PEG2-C2-acid 99.73% 否
HY-141386 Bromoacetamido-PEG2-C2-NHS ester ≥95.0% 否
HY-112706 PF-06747711 Antagonist 99.83% 否
HY-130683 Lenalidomide-propargyl-C2-NH2 hydrochloride 98.04% 否
HY-13836 ELQ-300 Inhibitor ≥98.0% 否
HY-122710A Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride Inducer ≥95.0% 否
HY-128832 Nutlin-C1-amido-PEG4-C2-N3 99.19% 否
HY-131880 Thalidomide-O-C2-acid Inducer 95.04% 否
HY-137531 Pomalidomide-PEG1-C2-COOH 99.76% 否
HY-100246 CI-1044 Inhibitor 98.02% 否
HY-102052 DCEBIO Activator 99.25% 否
HY-126512 Propargyl-C2-NHS ester ≥97.0% 否
HY-130414 Mal-amido-PEG4-acid 99.76% 否
HY-130713 Thalidomide-C2-amido-C2-COOH Inducer 98.45% 否
HY-133597 4-Chlorocatechol 99.37% 否
HY-134682 Fmoc-NH-PEG5-C2-NH2 98.06% 否
HY-135868 Mito-apocynin (C2) Inhibitor 98.38% 否
HY-139848 WS-898 Inhibitor 98.51% 否
HY-140543 N-DBCO-N-bis(PEG2-C2-acid) 96.65% 否
HY-140819 Bromo-PEG1-C2-azide 99.45% 否
HY-P2741 Maltose phosphorylase / 否
HY-P5881 PKCα (C2-4) inhibitor peptide Inhibitor 99.81% 否
HY-W749209 Sodium Acetate-1,2-13C2 98.60% 否
HY-N0830S10 Palmitic acid-13C2 Activator 99.54% 否
HY-W749251 5-Aminolevulinic acid-13C2,15N hydrochloride ≥99.0% 否
HY-13966S2 2-Deoxy-D-glucose-13C ≥98.0% 否
HY-B1337S5 Choline-13C2 chloride ≥98.0% 否
HY-112608 CHMFL-PI3KD-317 Inhibitor 98.04% 否
HY-122694A Thalidomide-O-amido-PEG-C2-NH2 hydrochloride Inducer 98.10% 否
HY-130521 Pomalidomide-amido-PEG3-C2-NH2 99.55% 否
HY-136163 (S,R,S)-AHPC-C2-NH2 dihydrochloride 98.63% 否
HY-103611 Thalidomide-O-amido-PEG3-C2-NH2 TFA Inducer 99.55% 否
HY-115384 Amino-PEG5-C2-acid ≥97.0% 否
HY-126949 Aminooxy-PEG3-azide ≥95.0% 否
HY-130531 NH-bis(C2-PEG2-NH-Boc) 99.93% 否
HY-131295 PD0325901-O-C2-dioxolane Inhibitor 98.62% 否
HY-136162 Thalidomide-4-O-C2-NH2 hydrochloride Inducer 99.37% 否
HY-137340 WH-10417-099 98.14% 否
HY-141240 Hydroxy-PEG2-C2-methyl ester 98.48% 否
HY-170872 PT-129 / 否
HY-17563S2 2'-Deoxyguanosine-13C10 99.8% 否
HY-B0389S15 D-Glucose-13C2-4 ≥98.0% 否
HY-N7627 Regaloside C ≥99.0% 否
HY-W127841 Citric acid-2,4-13C2 98.00% 否
HY-W580022 Pomalidomide-5'-PEG8-C2-COOH 98.21% 否
HY-133358 Cbz-NH-PEG12-C2-acid 95.66% 否
HY-66005S4 Acetaminophen-13C2,15N 98.30% 否
HY-N0091S3 Hypoxanthine-13C2,15N ≥91.0% 否
HY-W128417S 4-(Dimethylamino)phenacyl bromide-13C2,d6 98.14% 否
HY-W371165 C1s-IN-1 trihydrochloride Inhibitor 97.42% 否
HY-128716A Pomalidomide-PEG3-C2-NH2 TFA 99.0% 否
HY-107440A Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride Inducer 98.29% 否
HY-128591 DIPQUO Activator 98.70% 否
HY-108440 Shz-1 99.88% 否
HY-115450 ONO-0300302 Antagonist 99.43% 否
HY-126502 Mal-C2-NHS ester 99.30% 否
HY-126508 Mal-amido-PEG5-C2-​NHS ester ≥98.0% 否
HY-126509 Mal-amido-PEG10-C2-​NHS ester ≥98.0% 否
HY-126881 Fmoc-PEG2-C2-NHS ester 98.89% 否
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% 否
HY-130095 NHPI-PEG2-C2-NHS ester 98.23% 否
HY-130108 N3-PEG4-C2-Pfp ester ≥97.0% 否
HY-130488 Hydroxy-PEG2-C2-PFP ester ≥97.0% 否
HY-131866 (S,R,S)-CO-C2-acid ≥98.0% 否
HY-134512 Aminooxy-PEG3-C2-thiol / 否
HY-135085 Thiol-C2-PEG2-OH 97.83% 否
HY-141122 Boc-PEG4-C2-NHS ester / 否
HY-141242 Hydroxy-PEG4-C2-methyl ester ≥97.0% 否
HY-141380 Bromoacetamido-PEG2-C2-acid 99.11% 否
HY-141388 Bromoacetamido-PEG3-C2-Boc / 否
HY-148136 sEH inhibitor-7 Inhibitor 99.71% 否
HY-148346A STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA Agonist 98.30% 否
HY-160897 Methoxy-PEG-C3-amide-C2-Mal 99.69% 否
HY-169387 YT 6-2-PEG3-C2-NH2 Control / 否
HY-16973S Fluralaner-13C2,15N,d3 Inhibitor 98.35% 否
HY-B0031R Quetiapine hemifumarate (Standard) 99.87% 否
HY-D1546 Biotin-C2-maleimide 99.48% 否
HY-N0229S9 L-Alanine-13C2 ≥98.0% 否
HY-N0394S4 L-Cystine-3,3'-13C2 99.0% 否
HY-N6980 Licorice glycoside C2 99.07% 否
HY-W040795 N2-Acetylguanine 99.69% 否
HY-W777012 Acridinium C2 NHS ester 92.11% 否
HY-132212 LH1307 Inhibitor 96.9% 否
HY-150006 Pomalidomide-C2-acid 99.78% 否
HY-47373 Folate-PEG3-C2-acid 97.56% 否
HY-W013636S3 2-Ketoglutaric acid-13C Inhibitor 97.94% 否
HY-W015410S Disodium succinate-13C2 99.3% 否
HY-W017387S1 Sodium α-ketoisocaproic acid-13C2 98.1% 否
HY-W025074 BML-278 Activator 98.49% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 Inhibitor ≥98.0% 否
HY-107440 Thalidomide-O-amido-PEG3-C2-NH2 Inducer / 否
HY-112600A Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA Inducer 99.28% 否
HY-112617A Thalidomide-O-amido-PEG2-C2-NH2 TFA Inducer 99.72% 否
HY-129703A Thalidomide-PEG2-C2-NH2 TFA Inducer 99.39% 否
HY-130682 Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride / 否
HY-130853 Thalidomide-NH-PEG2-C2-NH-Boc Inducer 98.37% 否
HY-136160 Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride Inducer 99.12% 否
HY-167710 CRCD2 99.02% 否
HY-112599 Pomalidomide-PEG4-C2-NH2 95.11% 否
HY-103154 SB228357 Antagonist 99.43% 否
HY-113071 Mevalonic acid ≥99.0% 否
HY-120678 DBCO-PEG4-acid 98.87% 否
HY-120773 Fmoc-PEG3-C2-NHS ester ≥95.0% 否
HY-121982 Cyclo(L-Phe-L-Val) Inhibitor 99.88% 否
HY-125172 PolyQ aggregation inhibitor C2-8 Inhibitor / 否
HY-126381 Boc-N-PEG5-C2-NHS ester 96.91% 否
HY-126507 Mal-amido-PEG1-C2-​NHS ester 99.69% 否
HY-128716 Pomalidomide-PEG3-C2-NH2 / 否
HY-128716B Pomalidomide-PEG3-C2-NH2 hydrochloride 96.64% 否
HY-128846 Pomalidomide-C2-NH2 / 否
HY-130091 NHPI-PEG4-C2-NHS ester 98.88% 否
HY-130097 Ald-Ph-amido-PEG4-C2-acid 99.09% 否
HY-130104 Ald-Ph-amido-PEG2-C2-NHS ester 98.51% 否
HY-130470 Chloroacetamido-PEG4-C2-Boc ≥97.0% 否
HY-130489 Bromo-PEG5-C2-acid ≥98.0% 否
HY-130520 Bromoacetamido-PEG4-C2-Boc 99.84% 否
HY-133070 Tos-PEG5-C2-Boc / 否
HY-134512A Aminooxy-PEG3-C2-thiol hydrochloride ≥98.0% 否
HY-136395 Cartap Inducer / 否
HY-13677S1 6-Mercaptopurine-13C2,15N ≥96.0% 否
HY-138358 Azido-PEG23-C2-azide ≥95.0% 否
HY-138381 Br-PEG6-C2-NHBoc ≥98.0% 否
HY-138446 Amino-PEG4-C2-SH hydrochloride ≥95.0% 否
HY-138451 Amino-PEG7-C2-SH hydrochloride ≥98.0% 否
HY-138857A Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride 98.01% 否
HY-140001 Amino-PEG3-C2-sulfonic acid 99.47% 否
HY-140487 Cbz-NH-PEG2-C2-acid / 否
HY-140779 Azido-PEG6-C2-Boc 99.77% 否
HY-141116 Boc-N-PEG1-C2-NHS ester ≥97.0% 否
HY-141243 Hydroxy-PEG5-C2-methyl ester 98.97% 否
HY-141798 OICR-9429-N-C2-NH2 / 否
HY-144427S Vitamin E-13C2,d6 Inhibitor 98.0% 否
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% 否
HY-148080 Indole-C2-amide-C2-NH2 99.42% 否
HY-148346 STING agonist-20-Ala-amide-PEG2-C2-NH2 Agonist / 否
HY-148484 Pomalidomide-5'-PEG5-C2-COOH 98.80% 否
HY-156305 Coumarin-C2-exo-BCN 95.70% 否
HY-158470 Disialylated Core 2 O-glycan (C2S(3,3)2), 2-AB labelled / 否
HY-A0132S10 N-Acetyl-D-glucosamine-13C2,15N / 否
HY-B0166S3 L-Ascorbic acid-13C-2 ≥95.0% 否
HY-B0220S3 Erythromycin-13C2 Inhibitor ≥95.0% 否
HY-B0318S Metronidazole-13C2,15N2 99.30% 否
HY-B0579S3 Cyclosporin A-13C2,d4 95.21% 否
HY-I0960S Uracil-13C2,15N2 ≥97.0% 否
HY-N0229S15 L-Alanine-13C2,15N ≥99.0% 否
HY-N0437S3 Progesterone-13C2 Agonist 99.7% 否
HY-N0455AS5 L-Arginine-1,2-13C2 hydrochloride Activator 98.9% 否
HY-N0473S6 L-Tyrosine-3,5-13C2 99.43% 否
HY-N0666S6 L-Aspartic acid-1,4-13C2 ≥99.0% 否
HY-RS09537 NR2C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10511 PIK3C2A Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W008807S Phosphoenolpyruvic acid (potassium)-13C2 / 否
HY-W013495S Porphobilinogen-13C2 96.27% 否
HY-W015883S2 Fumaric acid-13C2,d2 98.00% 否
HY-W040329S1 2'-Deoxyadenosine-13C10 ≥99.0% 否
HY-W141374 CB096 98.72% 否
HY-W157376 PAMAM Dendrimer G0.0 amine (20% in methanol) Inhibitor / 否
HY-W654241 Isopentenyl pyrophosphate-13C2 ammonium 99.90% 否
HY-Y0674S Dicyandiamide-13C2,15N2 99.90% 否
HY-103708 Nezukone 98.81% 否
HY-114293S Acetyl coenzyme A-13C2 lithium Inhibitor 97.40% 否
HY-141941S Triazole Lactic Acid-13C2, 15N3 / 否
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% 否
HY-N0537S3 Xylose-2-13C 99.89% 否
HY-W006057AS17 Sodium 3-Methyl-2-oxobutanoic acid-13C2 99.90% 否
HY-W014780 α-Amylcinnamaldehyde 99.56% 否
HY-W017049S Trifluoroacetic acid-13C2 sodium / 否
HY-112600 Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 Inducer / 否
HY-112617 Thalidomide-O-amido-PEG2-C2-NH2 Inducer / 否
HY-112617B Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride Inducer / 否
HY-122694 Thalidomide-O-amido-PEG-C2-NH2 Inducer / 否
HY-128353 ROR agonist-1 Antagonist / 否
HY-129703 Thalidomide-PEG2-C2-NH2 Inducer / 否
HY-131308 Thalidomide-NH-C2-PEG3-OH Inducer / 否
HY-13966S4 2-Deoxy-D-glucose-13C-1 / 否
HY-141662 2',3'-cGAMP-C2-PPA Agonist / 否
HY-79369S1 Succinic anhydride-13C2 / 否
HY-B0031S4 Quetiapine hemifumarate-d8 99.35% 否
HY-B0389S14 D-Glucose-13C2 ≥98.0% 否
HY-B0782S1 Acetazolamide-13C2,d3 / 否
HY-B1449S3 Uridine-13C-2 / 否
HY-B1659S4 Glycerol-13C2 99% 否
HY-N0210S1 D-Galactose-13C-2 99.9% 否
HY-Y1250S6 Fmoc-Gly-OH-13C2,15N Inhibitor / 否
HY-122710 Thalidomide-O-amido-PEG4-C2-NH2 / 否
HY-125883 Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc / 否
HY-100441S1 Treprostinil-13C2,d1 Inhibitor / 否
HY-100582S1 Ribitol-2-13C / 否
HY-101047S1 D-erythro-Sphingosine-13C2,d2 / 否
HY-101108S1 Tazarotenic acid-13C2,d2 / 否
HY-101400S4 Deoxycytidine triphosphate-13C9 dilithium Activator / 否
HY-103155 SB-221284 Antagonist / 否
HY-106950CS1 Fosfructose-2-13C sodium / 否
HY-107698 PMPA (NMDA antagonist) Antagonist / 否
HY-108379 Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid / 否
HY-108826 Iduronate sulfatase / 否
HY-109506S9 DPPC-13C2 ≥95.0% 否
HY-110189S Pregnenolone monosulfate sodium-13C2,d2 / 否
HY-113071C (S)-Mevalonic acid / 否
HY-113150S2 Hexanoylglycine-13C2,15N / 否
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / 否
HY-113252S1 2-Methoxyestrone-13C6 / 否
HY-113263S1 17α-Hydroxypregnenolone-13C2,d2 / 否
HY-113295S Salicyluric acid-13C2,15N / 否
HY-113365S2 Cholestenone-13C2 / 否
HY-114293S4 Acetyl coenzyme A-13C2-1 sodium / 否
HY-115945 Complex III-IN-1 Inhibitor / 否
HY-116463A (2R,3S)-E1R Agonist 98.84% 否
HY-116700 Hinnuliquinone Inhibitor / 否
HY-116877 C2 Ceramide (d14:1/2:0) / 否
HY-117356A MRS2693 ammonium / 否
HY-117792 LY314228 Antagonist / 否
HY-118574 UBP141 Antagonist / 否
HY-12033S1 2-Methoxyestradiol-13C6 / 否
HY-121507 Hydroxy-PEG2-C2-sulfonic acid / 否
HY-121656 AKR1C2/3-IN-2 / 否
HY-123439 FTY720-C2 / 否
HY-124489S 2-Hydroxyestradiol-13C6 / 否
HY-125026 MyomiRs-IN-1 / 否
HY-12516S2 Desogestrel-13C2,d2-1 / 否
HY-125887 Boc-NH-PEG2-C2-amido-C4-acid / 否
HY-126026 NF-κB-IN-17 Inhibitor / 否
HY-126313 BnOH-NH-bis-(C2-S)-propane-O-isoprene ester / 否
HY-12650S Mirogabalin-13C2,d1 (Mixture of Diastereomers) / 否
HY-126510 MC-PEG2-C2-​NHS ester / 否
HY-126514 Propargyl-O-C1-amido-PEG2-C2-NHS ester / 否
HY-126515 Propargyl-O-C1-amido-PEG4-C2-NHS ester ≥95.0% 否
HY-126527 N3-PEG2-C2-PFP ester / 否
HY-126529 N3-PEG3-C2-PFP ester / 否
HY-126673 Mal-C2-Gly3-EDA / 否
HY-126677 Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA / 否
HY-128417S2 D-Glucose-1,6-13C2 / 否
HY-128741S2 D-Allose-13C-2 / 否
HY-128753S3 D-Lyxose-13C-2 / 否
HY-128793S trans-Stilbene-13C2 / 否
HY-129772 Phthalimide-PEG3-C2-OTs / 否
HY-130090 NHPI-PEG4-C2-Pfp ester / 否
HY-130092 NHPI-PEG3-C2-Pfp ester / 否
HY-130093 NHPI-PEG3-C2-NHS ester / 否
HY-130094 NHPI-PEG2-C2-Pfp ester / 否
HY-130096 Ald-Ph-amido-C2-nitrate / 否
HY-130102 Ald-Ph-amido-PEG3-C2-Pfp ester / 否
HY-130103 Ald-Ph-amido-PEG2-C2-Pfp ester / 否
HY-130105 Ald-Ph-amido-PEG1-C2-Pfp ester / 否
HY-130106 Ald-Ph-amido-PEG1-C2-NHS ester / 否
HY-130154 Ald-Ph-amido-PEG2-C2-acid / 否
HY-130164 Bromo-PEG3-C2-phosphonic acid / 否
HY-130174 Ald-Ph-amido-PEG3-C2-NH2 / 否
HY-130192 Cbz-NH-PEG8-C2-acid / 否
HY-130202 Ald-Ph-amido-PEG2-C2-Boc ≥97.0% 否
HY-130443 Cbz-NH-PEG6-C2-acid / 否
HY-130467 DNP-NH-PEG2-C2-acid / 否
HY-130491 DNP-NH-PEG4-C2-Boc / 否
HY-130599 Hydroxy-PEG2-CH2-Boc / 否
HY-130654 (S,R,S)-AHPC-C2-PEG4-N3 / 否
HY-130667 Ald-Ph-amido-C2-PEG3-azide 98.92% 否
HY-130669 Ald-Ph-amido-C2-PEG3-NH-Boc / 否
HY-130690 Propargyl-PEG1-SS-PEG1-C2-Boc ≥98.0% 否
HY-130712 NH2-C2-amido-C2-Boc / 否
HY-130758 Ald-PEG1-C2-Boc / 否
HY-130931 Propargyl-NH-PEG3-C2-NHS ester / 否
HY-131787A 2-Amino-ATP tetrasodium / 否
HY-131992 N-Acetylpsychosine / 否
HY-132973 MC-Val-Cit-PAB-NH-C2-NH-Boc ≥95.0% 否
HY-133069 Tos-PEG2-C2-Boc / 否
HY-133071 Tos-PEG6-C2-Boc / 否
HY-133410 Mal-C2-cyclohexylcarboxyl-hydrazide TFA / 否
HY-133410A Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride 98.23% 否
HY-133509 DBCO-C2-SulfoNHS ester / 否
HY-133546 Ald-Ph-amido-PEG11-C2-NH2 / 否
HY-133583 Propargyl-O-C1-amido-PEG3-C2-NHS ester / 否
HY-133694S 2-Aminoflubendazole-13C6 / 否
HY-13407S Gossypol-13C2 / 否
HY-13417S AICAR-13C2,15N / 否
HY-13458S1 Droxidopa-13C2,15N hydrochloride / 否
HY-135931 m-PEG11-C2-NHS Ester / 否
HY-135959 DBCO-NH-PEG7-C2-NHS ester / 否
HY-136162A Thalidomide-4-O-C2-NH2 Inducer / 否
HY-136163A (S,R,S)-AHPC-C2-NH2 / 否
HY-13623CS (1R,3S,4R)-ent-Entecavir-13C2,15N / 否
HY-13623S1 Entecavir-13C2,15N Inhibitor / 否
HY-136457S 2-NP-AHD-13C3 / 否
HY-136648S5 2'-Deoxyadenosine-5'-triphosphate-13C10 dilithium ≥95.0% 否
HY-13690S3 Mitotane-13C12 Inducer / 否
HY-138083 Parvodicin C2 Inhibitor / 否
HY-138098 Sartorypyrone B / 否
HY-138316 THP-PEG10-C2-Boc / 否
HY-138349 THP-PEG6-C2-Boc / 否
HY-138362 Br-PEG6-C2-acid / 否
HY-138370 Boc-NH-PEG4-C2-Boc / 否
HY-138375 Mal-PEG5-C2-NH2 hydrochloride / 否
HY-138380 Mal-PEG4-C2-NH2 TFA 98.60% 否
HY-138384 Br-PEG9-C2-NHBoc / 否
HY-138390 NH2-PEG10-C2-dimethylamino / 否
HY-138397 Boc-NH-PEG15-C2-acid / 否
HY-138399 Boc-NH-PEG22-C2-NH2 / 否
HY-138406 Boc-NH-PEG8-C2-Br / 否
HY-138410 Boc-NH-PEG11-C2-acid / 否
HY-138425 Amino-PEG12-C2-azide / 否
HY-138432 Boc-NH-PEG26-C2-NH2 / 否
HY-138464 Br-Boc-C2-azido / 否
HY-138474 Boc-PEG1-PPG2-C2-azido / 否
HY-138485 Boc-PEG1-PPG2-C2-NH2 / 否
HY-138535 Azide-C2-Azide / 否
HY-138616S3 dGTP-13C10 dilithium 98.8% 否
HY-138849 Thalidomide-NH-amido-C2-NH2 Inducer / 否
HY-138849A Thalidomide-NH-amido-C2-NH2 hydrochloride Inducer / 否
HY-138854 Thalidomide-NH-amido-PEG1-C2-NH2 Inducer / 否
HY-138854A Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride Inducer / 否
HY-138855 Thalidomide-NH-amido-PEG2-C2-NH2 Inducer / 否
HY-138855A Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride Inducer / 否
HY-138856 Thalidomide-NH-amido-PEG3-C2-NH2 Inducer / 否
HY-138856A Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride Inducer / 否
HY-138857 Thalidomide-NH-amido-PEG4-C2-NH2 / 否
HY-138965A Pomalidomide-5-C2-NH2 hydrochloride / 否
HY-139084 XL388-C2-NH2 / 否
HY-139085A XL388-C2-amide-PEG9-NH2 hydrochloride ≥95.0% 否
HY-139085B XL388-C2-amide-PEG9-NH2 TFA 95.97% 否
HY-140011 Acid-C2-PEG3-NHS ester / 否
HY-140067 endo-BCN-PEG2-C2-NHS ester ≥95.0% 否
HY-140085 N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) / 否
HY-140101 Azido-C2-SS-PEG2-C2-acid / 否
HY-140164 Azido-PEG2-C2-sulfonic acid / 否
HY-140221 Azido-PEG1-C2-methylamine / 否
HY-140287 DBCO-C2-PEG4-amine / 否
HY-140294 DBCO-C2-PEG4-NH-Boc / 否
HY-140349 AZD-CO-C2-Ph-amido-Ph-azide / 否
HY-140406 Aminooxy-PEG3-C2-NH-Boc / 否
HY-140489 Cbz-NH-PEG5-C2-acid / 否
HY-140514 NH-bis(PEG2-C2-acid) / 否
HY-140550 NH-bis(C2-PEG1-azide) / 否
HY-140554 N-Boc-N-bis(C2-PEG1-azide) / 否
HY-140595 m-PEG3-S-PEG1-C2-Boc / 否
HY-140633 Ald-C2-PEG4-azide / 否
HY-140750 Benzyloxy carbonyl-PEG3-C2-Boc / 否
HY-140776 Azido-PEG2-C2-Boc / 否
HY-140834 Boc-N-Amido-PEG2-C2-azide / 否
HY-141199 Bromoacetamido-C2-PEG2-NH-Boc / 否
HY-141239 Hydroxy-PEG1-C2-methyl ester / 否
HY-141241 Hydroxy-PEG3-C2-methyl ester / 否
HY-141245 Hydroxy-PEG4-C2-nitrile / 否
HY-141323 C2-Bis-phosphoramidic acid diethyl ester / 否
HY-141349 S-Acetyl-PEG3-C2-acid / 否
HY-141381 Bromoacetamido-PEG3-C2-acid / 否
HY-141663 2',3'-cGAMP-C2-SH / 否
HY-141878 di-Ellipticine-RIBOTAC Modulator / 否
HY-143683S Theophylline-13C2,d6 / 否
HY-143784S C14 Benzalkonium-1 acid-13C2,d11 chloride / 否
HY-143943S Felodipine 3,5-dimethyl ester-13C2,d6 / 否
HY-144128 hGGPPS-IN-1 / 否
HY-144129 hGGPPS-IN-2 / 否
HY-144130 hGGPPS-IN-3 / 否
HY-144150S Pelubiprofen impurity 2-13C2,d6 / 否
HY-144153S S-(1,2-Dichlorovinyl)glutathione-13C2,15N / 否
HY-145247 Biotin-PEG7-C2-S-Vidarabine Inhibitor / 否
HY-145248 Biotin-PEG7-C2-NH-Vidarabine-S-CH3 Inhibitor / 否
HY-145253 Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-145255 Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-14544AS Quetiapine-d4 hydrochloride / 否
HY-14608S10 L-Glutamic acid-13C2 / 否
HY-146194 NHEJ inhibitor-1 Activator / 否
HY-146196 Anticandidal agent-1 Inhibitor / 否
HY-146573 AKR1C3-IN-6 Inhibitor / 否
HY-146966S 2-NP-DNSAH-13C6 / 否
HY-146994S2 L-Idose-13C-2 / 否
HY-146995S1 Glycolaldehyde-2-13C / 否
HY-14749AS1 Pyronaridine tetraphosphate-13C2,d4 / 否
HY-147716 CDK8-IN-6 Inhibitor / 否
HY-147717 CDK8-IN-7 Inhibitor / 否
HY-147835 Antibacterial agent 109 Inhibitor / 否
HY-148171 L-2'-Fd4C Inhibitor / 否
HY-148472A C2-Amide-C4-NH2 / 否
HY-148662 Pomalidomide-PEG5-C2-NH2 hydrochloride / 否
HY-149255 PTP1B/AKR1B1-IN-2 Inhibitor / 否
HY-149917 ITK degrader 1 Degrader / 否
HY-150623 SARS-CoV-2 nsp13-IN-2 Inhibitor / 否
HY-150631S Glutathione-glycine-13C2,15N trifluoroacetate / 否
HY-150797 QA-68 Inhibitor / 否
HY-150915S Uracil 4,5-13c2 / 否
HY-150980S 1,2-O-Isopropylidene-β-L-idofuranuronic-6-13C acid γ-lactone / 否
HY-150981S 1,2-O-Isopropylidene-a-D-glucofuranuronic-6-13C acid, γ-lactone / 否
HY-152297 (1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol / 否
HY-152305 (1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol / 否
HY-152463 4′-C-2-Propen-1-yluridine / 否
HY-153042 Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride / 否
HY-153371 50-C2-C9-4tail / 否
HY-153538 AP-C2 Inhibitor / 否
HY-15388S1 Tazarotene-13C2,d2 / 否
HY-155705 BMP agonist 1 / 否
HY-156304 Coumarin-C2-TCO 98.10% 否
HY-156882 Biotin-PEG3-amide-C2-CO-Halofuginone / 否
HY-157182 DNP-PEG2-NHCO-C2-DBCO / 否
HY-157386S 8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 / 否
HY-157588 (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH Inducer / 否
HY-157749 Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157758 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157759 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH Inducer / 否
HY-157760 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH Inducer / 否
HY-160449 p53 Activator 10 Activator / 否
HY-160514 LXQ46 Inhibitor / 否
HY-161183 (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc Inducer / 否
HY-161184 Deoxy-thalidomide-piperidine-C-piperazine-C2-OH Inducer / 否
HY-161186 Thalidomide-piperidine-C-azetidine-C2-O-C-boc Inducer / 否
HY-161188 Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH Inducer / 否
HY-161189 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc Inducer / 否
HY-161190 Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH Inducer / 否
HY-161191 Thalidomide-azetidine-piperazine-C2-O-C2-OH Inducer / 否
HY-161197 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH Inducer / 否
HY-161199 Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH Inducer / 否
HY-161200 Thalidomide-piperazine-C-azetidine-C2-OH Inducer / 否
HY-161202 Thalidomide-piperidine-O-piperidine-C2-OH Inducer / 否
HY-161203 Thalidomide-azetidine-piperazine-C2-O-C-boc Inducer / 否
HY-161250 Pomalidomide-NH-PEG6-amide-C2-CPI-1612 / 否
HY-161393 RB-CO-PEG5-C2-CO-VH032 / 否
HY-161394 SPRT / 否
HY-161767 JWJ-01-306 / 否
HY-161839 AKR1C2/3-IN-1 Inhibitor / 否
HY-161910 SH-E4A-66 Inhibitor / 否
HY-162046 Anticancer agent 178 Inducer / 否
HY-162081 BTK-IN-32 Inhibitor / 否
HY-16271S Kevetrin hydrochloride-13C2,15N3 p53 Activator / 否
HY-163078 C2-Gal-Dox / 否
HY-163224 (S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / 否
HY-163228 PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / 否
HY-163276 OX2R-IN-2 Agonist / 否
HY-163788 C5-CONH-C2-N-CH3 / 否
HY-163903 OH-C2-PEG3-NHCO-C3-COOH / 否
HY-163904 (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH / 否
HY-163930 (S,R,S)-AHPC-CO-cyclohexane-C2 / 否
HY-163986 Pomalidomide-C2-NHCO-C6 / 否
HY-164210 DBCO-PEG2-C2-acid / 否
HY-164212 DBCO-PEG1-OH / 否
HY-164785 TCO-PEG5-C2-Mal ≥95.0% 否
HY-164909 PZ-3022 / 否
HY-166889S 2,4,5-Trichloro-4'-methoxy-biphenyl-13C12 / 否
HY-166914S 2,2',3,3',4,5,5'-Heptachloro-4'-methoxybiphenyl-13C12 / 否
HY-166925S 2′,3,3′,4′,5,5′-Hexachloro-4-biphenylol-13C12 / 否
HY-166935S 2,3-Dibromo-7,8-dichloro-dibenzofuran-13C12 / 否
HY-166940S 2′,3′,4′,5′-Tetrachloro-4-biphenylol-13C12 / 否
HY-166952S 2′,3,4′,5,5′-Pentachloro-4-biphenylol-13C12 / 否
HY-166961S 2′,4′,5′-Trichloro-4-biphenylol-13C12 / 否
HY-167810A Cyclosporin A Acetate-13C2,d4 / 否
HY-167906S Hexadecyl 2-((4-Nitrophenyl)thio)acetate-13C2 / 否
HY-168019 (S,R,S)-AHPC-PEG2-C2-boc / 否
HY-168298 Lenalidomide-6-F-piperidine-C2-Pip-C-COOH / 否
HY-168312 Thalidomide-NH-C2-2-azaspiro[3.3]heptane / 否
HY-168388 Piperidine-C2-piperazine-Boc / 否
HY-168389 Thalidomide-piperidine-C2-piperazine-Boc / 否
HY-168708 AH2-14c 98.01% 否
HY-168724 Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH Degrader / 否
HY-169082 JQ-1 (carboxylic acid)-NH-C2-NH-COOH / 否
HY-169141 BIIB021-NH-C2-piperidine-CO-Me / 否
HY-169150 JQ-1 carboxylic acid-PEG3-C2-NH2 / 否
HY-169150A JQ-1 carboxylic acid-PEG3-C2-NH2 hydrochloride / 否
HY-169236 COOH-C-PEG2-NHCO-C2-COOH / 否
HY-169237 Pomalidomide-C2-CONH-PEG2-C-COOH / 否
HY-169364 2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc Ligand / 否
HY-169378 CSI86 Degrader / 否
HY-169385 ATC-324 Degrader / 否
HY-169395 (S,R,S)-AHPC-CO-PEG-C2-iodine / 否
HY-169397 Thalidomide-NH-CH2-CONH-C2-PEG-bromine / 否
HY-169433 Naph-Se-TMZ Inhibitor / 否
HY-169437 Nitro-Naphthalimide-C2-acylamide / 否
HY-169438 NNISC-2 / 否
HY-170335 PROTAC c-Met degrader-2 Degrader / 否
HY-170691 hAChE/hBuChE-IN-1 Inhibitor / 否
HY-170867 Nrf2/HO-1 activator 3 / 否
HY-172117 Boc-methylglycine-C2-bromine / 否
HY-172126 JQ-1 (carboxylic acid)-NH-C2-NH-AMPRO-222 / 否
HY-172144 JB300 Degrader / 否
HY-172145 Thalidomide-O-CH2-CO-NH-C2-PEG2-NH-Boc / 否
HY-172823 NH2-C2-PEG8-Succinamic acid / 否
HY-172902 RNA binder 1 / 否
HY-172951 Antitrypanosomal agent 23 Inhibitor / 否
HY-173132 AKR1Cs-IN-1 Inhibitor / 否
HY-173409 AR antagonist 11 / 否
HY-173520 EGFR/HDAC-IN-1 Inhibitor / 否
HY-173623 EU 1622-240 Activator / 否
HY-17416AS1 Guanfacine-15N3,13C2 Agonist / 否
HY-174235 Thalidomide-OCH2-amide-PEG2-C2-Boc / 否
HY-174379 KRAS IN-44 / 否
HY-174858 dASK1-VHL / 否
HY-174861 (S,R,S)-AHPC-CO-C2-PEG-NHCO-C2-COOH / 否
HY-174863 Pomalidomide-C2-PEG-NHCO-C2-COOH / 否
HY-17530S Aldicarb sulfone-13C2,d3 Inhibitor / 否
HY-176182 Br-C2-PEG3-OTs Chemical / 否
HY-176188 Lenalidomide-5-Br-amide-C2-Br / 否
HY-176202 TLR7/8 agonist 12-PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC / 否
HY-176240 FBnG-amino-PEG3-C2-azido Inducer / 否
HY-176536 (S,R,S)-AHPC-amide-PEG5-C2-azide / 否
HY-176726 ZnPc-amide-PEG3-C2-NH2 Inducer / 否
HY-18572S 2,4-D-13C6 Inhibitor / 否
HY-34628S2 Tri-O-acetyl-D-glucal-13C-2 / 否
HY-40171S NH2-C2-NH-Boc-d4 / 否
HY-48394A Bis-S-C2-N(N-Me)-C2-OH dihydrochloride / 否
HY-77956S2 Thyminose-13C-2 / 否
HY-90009AS Tadalafil-13C2,d3 / 否
HY-90009AS1 Tadalafil-13C2,d3-1 / 否
HY-A0084S1 Procainamide-13C2 hydrochloride / 否
HY-B0031S3 Quetiapine-d8 hemifumarate / 否
HY-B0031S5 Quetiapine-d4-1 fumarate / 否
HY-B0101S1 Fluconazole-13C2,15N Inhibitor / 否
HY-B0141S5 Estradiol-13C2 Agonist / 否
HY-B0149S3 Tranexamic acid-13C2,15N / 否
HY-B0151S1 Pregnenolone-13C2,d2 / 否
HY-B0216S2 Ethynyl Estradiol-13C2 Agonist / 否
HY-B0228S2 Adenosine-2′-13C / 否
HY-B0234S3 Estrone-13C2 Agonist / 否
HY-B0283S1 Acipimox-13C2,15N2 / 否
HY-B0389S12 D-Glucose-13C-2 / 否
HY-B0389S22 D-Glucose-13C2,d2 / 否
HY-B0400S3 D-Sorbitol-13C-2 / 否
HY-B0495S3 Lamotrigine-13C2,15N / 否
HY-B0495S6 Lamotrigine-13C2,15N2,d3 / 否
HY-B0508S1 Ornidazole-13C2,15N2 Inhibitor / 否
HY-B0523S Anagrelide-13C2,15N,d2 / 否
HY-B0712S1 Ceftriaxone-13C2,d3 triethylammonium salt Inhibitor / 否
HY-B0863S3 Glyphosate-13C2,15N Inducer ≥98.0% 否
HY-B1118S1 Secnidazole-13C2, 15N2 Inhibitor / 否
HY-B1640S Ethacrynic acid-13C2,d5 / 否
HY-B1842S Fluroxypyr-13C2 / 否
HY-B1912S1 Amidosulfuron-13C2,d6 / 否
HY-CE00156 (2S)-Pristanoyl-CoA / 否
HY-CE00612 2'-(5''-Phosphoribosyl)-3'-dephospho-CoA / 否
HY-CE00614 2'-(5-Triphosphoribosyl)-3'-dephospho-CoA / 否
HY-D0184S5 2'-Deoxycytidine-13C9 96.8% 否
HY-D1551 10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / 否
HY-I0400S2 N-Acetylneuraminic acid-13C-2 / 否
HY-I0626S Cytosine-13C2,15N3 / 否
HY-I0736S Isonicotinic acid-d4 98.12% 否
HY-N0059S2 D-arabinose-13C-2 / 否
HY-N0376R Liquiritin (Standard) / 否
HY-N0379S7 D-Mannose-13C-2 / 否
HY-N0390S10 L-Glutamine-1,2-13C2 / 否
HY-N0538S1 Xylitol-2-13C / 否
HY-N0545S Taurocholic acid-13C2,15N sodium Agonist / 否
HY-N0602R Ginsenoside Rg2 (Standard) Inhibitor / 否
HY-N0666S7 L-Aspartic acid-1,4-13C2,15N / 否
HY-N0733S1 Glucosamine-2-13C hydrochloride / 否
HY-N10595 Ladanetin-6-O-β-(6′′-O-acetyl)glucoside / 否
HY-N10642 Pedaliin 6''-acetate / 否
HY-N10869 Pseudolaric acid C2-O-β-D-glucoside / 否
HY-N1150S4 Thymidine-13C-2 / 否
HY-N1150S5 Thymidine-2′-13C / 否
HY-N11857 Gentamicin C2 Inhibitor / 否
HY-N12297 Ciwujianoside C2 Activator / 否
HY-N12447 C-2′-Decoumaroylaloeresin G / 否
HY-N1420AS2 Rhamnose-13C-2 monohydrate ≥99.0% 否
HY-N1428S2 Citric acid-13C2 / 否
HY-N1480S2 (-)-Fucose-13C-2 / 否
HY-N1517A (Rac)-Ganoderic acid C2 Inhibitor / 否
HY-N3205 Neochamaejasmin B ≥95.0% 否
HY-N3231 Murraol Inhibitor / 否
HY-N3671 Cycloshizukaol A / 否
HY-N3686S2 D-Arabitol-13C-2 / 否
HY-N3697 Demethoxydeacetoxypseudolaric acid B 99.94% 否
HY-N6625S Chlorothalonil-13C2 Inhibitor / 否
HY-N6910 Pseudolaric Acid C2 99.17% 否
HY-N7092S3 D-Fructose-13C2 ≥98.0% 否
HY-N7398S 2-Pentylfuran-13C2 / 否
HY-N9468 Gentamicin C2a Inhibitor / 否
HY-P10053 sPLA2-IIA Inhibitor Inhibitor / 否
HY-P6176 JLB2-110c Inhibitor / 否
HY-R00539 hsa-miR-30c-2-3p mimic / 否
HY-R00539A hsa-miR-30c-2-3p agomir / 否
HY-RI00539 hsa-miR-30c-2-3p inhibitor / 否
HY-RI00539A hsa-miR-30c-2-3p antagomir / 否
HY-RS00535 AKR1C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01199 ATP2C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01227 ATP6V1C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01738 C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01740 C2CD3 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01741 C2CD5 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01742 C2orf69 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05907 GTF3C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05968 H3C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05975 H4C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06265 HNRNPC Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS09538 NR2C2AP Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS09547 NR3C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS09548 Nr3c2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS09549 Nr3c2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS09609 NT5C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10512 Pik3c2a Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10513 Pik3c2a Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10514 PIK3C2B Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10515 Pik3c2b Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10516 Pik3c2b Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10517 PIK3C2G Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10518 Pik3c2g Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10519 Pik3c2g Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS14017 SULT1C2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W005355S9 Sodium 2-oxobutanoate-13C4 / 否
HY-W006057AS Sodium 3-methyl-2-oxobutanoate-13C2,d1 / 否
HY-W006057AS3 Sodium 3-methyl-2-oxobutanoate-13C2,d4 / 否
HY-W007318S 2-Iodoaniline-13C6 / 否
HY-W007928S1 1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C-1 / 否
HY-W008048S 2',3'-O-Isopropylideneadenosine-13C5 / 否
HY-W008507S (R)-2,3-Dihydroxypropanal-3-13C / 否
HY-W010042S2 L-Glucose-13C-2 / 否
HY-W010452S2 3-Hydroxybutyric acid-13C2 sodium / 否
HY-W011683S1 2'-Deoxyadenosine monohydrate-2′-13C / 否
HY-W012684S Ethane-1,2-diamine-13C2 dihydrochloride / 否
HY-W012864S1 (2S,3R)-2,3,4-Trihydroxybutanal-13C-1 / 否
HY-W013061S5 Propane-1,2,3-triyl tripalmitate-13C2 / 否
HY-W013636S4 2-Ketoglutaric acid-13C2 Inhibitor / 否
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / 否
HY-W015883AS Fumaric acid2,3-13C2 disodium / 否
HY-W015883S1 Fumaric acid-13C2 / 否
HY-W015913S4 2-Oxopropanoate-13c2 sodium / 否
HY-W016009S3 2'-Deoxyadenosine-5'-monophosphate-13C10 dilithium / 否
HY-W017018S1 L-Ornithine-1,2-13C2 hydrochloride / 否
HY-W017072S 1-Dodecene-1,2-13C2 / 否
HY-W017522S6 Adipic acid-13C2 Inhibitor / 否
HY-W018241S 2,2'-Sulfonyldiethanol-13C4 / 否
HY-W018772S16 D-Ribose-1,2-13C2 / 否
HY-W018772S3 D-Ribose-13C-2 / 否
HY-W019796 Cbz-NH-PEG4-C2-acid / 否
HY-W035903S Ethanolamine-13C2 hydrochloride / 否
HY-W040028 Cartap hydrochloride Inducer / 否
HY-W040240S2 (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 / 否
HY-W042357S3 Ac-rC Phosphoramidite-13C2,d1 / 否
HY-W048482S rU Phosphoramidite-13C2,d1 / 否
HY-W096111A Trt-PEG4-C2-acid hydrate / 否
HY-W096132 Dimethylamino-PEG2-C2-NH2 / 否
HY-W099580S Hexadecane-1,2-13C2 / 否
HY-W100312S o-Toluidine-13C6 hydrochloride / 否
HY-W1049085 mPEG-SS (MW 1000) / 否
HY-W1049085A mPEG-SS (MW 5000) / 否
HY-W1049085B mPEG-SS (MW 10000) / 否
HY-W1049085C mPEG-SS (MW 20000) / 否
HY-W1049085D mPEG-SS (MW 40000) / 否
HY-W1049085E mPEG-SS (MW 2000) / 否
HY-W1049085H mPEG-SS (MW 3400) / 否
HY-W338294S1 2'-Deoxycytidine-13C-2 monohydrate / 否
HY-W440881A DSPE-PEG-C2-DBCO sodium (MW 3400) / 否
HY-W584529 VH032-C2-NH-Boc / 否
HY-W584532 VH032-O-C2-NH-Boc / 否
HY-W588192S 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 / 否
HY-W590667 C2 Ceramide-1-phosphate / 否
HY-W654105 C18-Ceramide-13C2,d2 / 否
HY-W654109 2-Chloroanthracene-13C6 / 否
HY-W654190 Fipronil sulfone-13C2,15N2 / 否
HY-W706737 N-Deschlorobenzoyl indomethacin-d3 / 否
HY-W709340 N-Boc-S-Bzl-L-Cys-Gly-OBzl-13C2,15N / 否
HY-W721606 Chlorantraniliprole-d6 / 否
HY-W747168 Ethyl Vinyllactate-13C2,d3 / 否
HY-W747216 2,4-Dichloro-5-methylpyrimidine-15N2,13C / 否
HY-W747218 2-Chloro-5-methylpyrimidin-4-amine-15N2,13C / 否
HY-W747751 Sorbic acid-13C2 / 否
HY-W747791 4,6-Dichloro-1,3,5-triazin-2-amine-13C3 / 否
HY-W747821 2,5,6-Triaminopyrimidin-4(3H)-one-13C2,15N / 否
HY-W747877 Methyl 2-aminoacetate hydrochloride-13C2,15N / 否
HY-W747965 8-Bromoguanosine-13C2,15N / 否
HY-W747970 2’,3’,5’-Tri-O-acetyl guanosine-13C2,15N / 否
HY-W747971 N2-Acetyl-O6-diphenylcarbamoylguanine-13C2,15N / 否
HY-W747973 N2,9-Diacetylguanine-13C2,15N / 否
HY-W748002 a-Methyl-2-piperidinemethanol-13C2 / 否
HY-W748282 2,3,3',4,4',5,5',6-Octachloro-1,1'-biphenyl-13C12 / 否
HY-W748284 2,4,4'-Trichloro-1,1'-biphenyl-13C12 / 否
HY-W748285 2-Octanamidoacetic acid-13C2,15N / 否
HY-W748291 2,3,4,4',5-Pentachloro-1,1'-biphenyl-13C12 / 否
HY-W748314 2,2',6-Trichloro-1,1'-biphenyl-13C12 / 否
HY-W748332 PCB118-13C12 / 否
HY-W748349 2,2',3,3',4,4',5,5'-Octachloro-1,1'-biphenyl-13C12 / 否
HY-W748354 2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl-13C12 / 否
HY-W748355 2,2',3,3',5,5',6,6'-Octachloro-1,1'-biphenyl-13C12 / 否
HY-W748626 Acetic acid, 2-bromo-, hexadecyl ester-13C2 / 否
HY-W749377 1,2,3,4,5-Pentabromo-6-methylbenzene-13C6 / 否
HY-W749645 Acrolein 2,4-Dinitrophenylhydrazone-13C6 / 否
HY-W750238 Scoparone-13C2,d6 / 否
HY-W750263 Pyruvic acid-13C2 / 否
HY-W750553 2-Ethylhexyl 2-cyanoacetate-13C3 / 否
HY-W751444 2,4-Dimethylanisole-13C6 / 否
HY-W753207 Porphobilinogen-13C2,15N / 否
HY-W753343 2-Chloro-N-phenylacetamide-13C6 / 否
HY-W753344 2-(2,6-Dichlorophenoxy)-N-phenylacetamide-13C6 / 否
HY-W753345 2,6-Dichlorodiphenylamine-13C6 / 否
HY-W753370 2,4,5-Trichloronitrobenzene-13C6 / 否
HY-W753569 Octopamine (Acetic Acid)-13C2,15N / 否
HY-W754052 N-Butyrylglycine-13C2,15N / 否
HY-W754053 N-(2-Methylbutyryl)glycine-13C2,15N / 否
HY-W754054 Propionylglycine (Standard)-13C2,15N / 否
HY-W754216 Diacetone-β-D-fructose-13C6 / 否
HY-W754548 Glycocholic acid-13C2,d4 / 否
HY-W755720 Tiglyl Glycine-13C2,15N Methyl Ester / 否
HY-W759458 N-Phthaloylglycine-13C2,15N / 否
HY-W759459 Meldrum's acid-13C3 / 否
HY-W765303 N-Pivaloylglycine-13C2,15N / 否
HY-W765357 Glycine-13C2,15N p-Toluenesulfonate / 否
HY-W765992 N-Boc-erythro-sphingosine-13C2,d2 / 否
HY-W765997 Didanosine-13C2,15N / 否
HY-W766136 Aprepitant Impurity 9-13C2,d2 / 否
HY-W766769 Cyproterone Acetate-13C2,d3 Antagonist / 否
HY-W767035 O6-Benzyl-N2,3-etheno Guanosine-13C2,d1 / 否
HY-W767285 6-Amino-5-nitrosouracil-13C2 / 否
HY-W767601 (3S,6S)-3,6-Dimethyl-1,4-dioxane-2,5-dione-13C2 / 否
HY-W768057 Acetamide-13C2,15N / 否
HY-W768168 N-Acetyl-D-neuraminic Acid-13C2 / 否
HY-W768178 2-Amino-2-deoxyglucose hydrochloride-13C2 / 否
HY-W768188 (2r,4r)-Pentane-1,2,3,4,5-pentaoll-13C2 / 否
HY-W768211 2-Deoxy-2-fluoro-D-glucose-13C6 / 否
HY-W768220 D-Fructose-1,2-13C2 / 否
HY-W768245 a-D-Galactose-1,2-13C2 1-phosphate potassium / 否
HY-W768482 2-Amino-6-hydroxypyrimidin-4(1H)-one-13C2 / 否
HY-W768491 3',5'-Di-O-benzyl Entecavir-13C2,15N / 否
HY-W768637 N-(3-Indolylacetyl)glycine-13C2,15N / 否
HY-W768772 Fluroxypyr-13C2,d2 / 否
HY-W768963 2-(1-Cyanoethyl)indole-13C2,15N / 否
HY-W769077 N-Valerylglycine-13C2,15N / 否
HY-W769079 N-Isovaleroylglycine-13C2,15N / 否
HY-W769081 Tiglyl Glycine-13C2,15N / 否
HY-W769169 N-Isobutyrylglycine-13C2,15N / 否
HY-W769171 Suberylglycine-13C2,15N / 否
HY-W769723 3-Hydroxyhippuric acid-13C2,15N / 否
HY-W769991 Lactate sodium-13C2 / 否
HY-W770176 2-Benzyl-5-chlorobenzaldehyde-13C6 / 否
HY-W770677 9-Carboxymethoxymethylguanine-13C2,15N / 否
HY-W771037 2-Oxoarginine-13C6 / 否
HY-W771062 8-Aminoguanosine-13C2,15N / 否
HY-W771063 8-Aminoguanine-13C2,15N / 否
HY-W777037 2,3-Dichlorobenzamidyl Guanidine-13C2 / 否
HY-W777079 Valdecoxib-13C2,15N / 否
HY-W777099 N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[13C2,15N]-OBzl / 否
HY-W777154 Zoledronic acid-15N2,13C2 / 否
HY-W777297 Lapatinib-13C2,15N Ditosylate / 否
HY-W777329 (4E)-4-Octenedioic acid-13C2 / 否
HY-W777360 Harman-13C2,15N Inhibitor / 否
HY-W777674 2,6-Deoxyfructosazine-13C4 / 否
HY-W777675 2,5-Deoxyfructosazine-13C4 / 否
HY-W777809 Guanine-13C2,15N / 否
HY-W777833 Ethyl 2-(6-nitro-2,3-dichlorobenzyl)glycine-13C2 / 否
HY-W777836 2,2-Dibromomalonamide-13C3 / 否
HY-W778114 Guanine-13C2,7-15N / 否
HY-W778152 O,O-Dimethyl Phosphorothionate ammonium-13C2 / 否
HY-W778162 Phenanthrene-13C2 / 否
HY-W778202 2-Oxoacetic acid hydrate-13C2 / 否
HY-W778203 Glycolic acid-13C2 / 否
HY-W778257 2-Amino-4,6-dichloropyrimidine-13C2 / 否
HY-W778297 5,6-Diamino-4-thiouracil-13C2 / 否
HY-W778300 Sodium 2-cyanoacetate-13C2 / 否
HY-W778335 Dimethyl Phthalate-13C2 / 否
HY-W778362 4-Chloro kynurenine-13C2,15N / 否
HY-W778393 cis-Tranexamic acid-13C2,15N / 否
HY-W778521 Acetic acid-13C2,d3 sodium ≥99.0% 否
HY-W778716 2-(1-Ethoxyethylidene)malononitrile-13C2 / 否
HY-W778771 Benz[a]anthracene-7-acetic Acid-13C2 / 否
HY-W778772 Benz[a]anthracene-7-acetonitrile-13C2 / 否
HY-W778790 Ethyl 2-formamido-3-hydroxyacrylate-13C2 / 否
HY-W778791 N-Formylglycine ethyl ester-13C2 / 否
HY-W778954 2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3 / 否
HY-W778990 2-Deoxyuridine-1,2,3,4,5-13C5 / 否
HY-W779008 2-Hydroxyacetaldehyde-13C2 / 否
HY-W779191 MeIQx-13C / 否
HY-W779386 N-Acetylglycine-13C2,15N / 否
HY-W779404 Ribavirin-13C2 / 否
HY-W779904 H-Gly-OBzl.TosOH-13C2,15N / 否
HY-W780293 2-Phenylphenol-13C6 / 否
HY-W781971 Estradiol 17-Benzoate-13C2 / 否
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% 否
HY-W957364 Pomalidomide-C2-Br / 否
HY-Y0219S 1,2,4-Triazole-13C2,15N3 / 否
HY-Y0262BS Oxalic Acid-13C2 disodium / 否
HY-Y0319S2 Acetic acid-13C2 / 否
HY-Y0338S1 Ethylene glycol-13C2 / 否
HY-Y0383S2 Dimethyl terephthalate-13C2-1 / 否
HY-Y0418S2 Dulcite-13C-2 / 否
HY-Y0677S Carbethoxymethyldiethyl phosphonate-C13 / 否
HY-Y0781S3 Pyruvic acid-13C-2 sodium / 否
HY-Y0946S1 Acetamide-13C2 / 否
HY-Y0966S11 Glycine-13C2,15N,d2 / 否
HY-Y0989S2 Acetophenone-1,2-13C2 / 否
HY-Y1088S Hydrocinnamic acid-2,3-13C2 / 否
HY-Y1250S5 Fmoc-Gly-OH-13C2 / 否
HY-100043S 2-Ethyl-3,5-dimethylpyrazine-13C2 / 否
HY-10218S1 Everolimus-13C2,d4 / 否
HY-10285S2 Saxagliptin-13C2 Inhibitor / 否
HY-10466S1 Daclatasvir-13C2,d6 Inhibitor / 否
HY-111095S3A D-(-)-Lactic acid-13C-2 sodium / 否
HY-118560S Tricyclodecenyl acetate-13C2 / 否
HY-119799 UK-500001 Inhibitor / 否
HY-125571 A 74704 Inhibitor / 否
HY-126830 Antifolate C2 / 否
HY-129252 Prothracarcin Inhibitor / 否
HY-129503S 2-Heptyl-4-quinolone-13C6 / 否
HY-130155 AMPK activator C2 Activator / 否
HY-132031 Mal-Val-Ala-PAB(C2-glucuronic acid)-DMEA-PNU-159682 / 否
HY-132223 LH1306 Inhibitor / 否
HY-132644S1 3-Demethyl Thiocolchicine--13C2,d6 / 否
HY-135928 Biotin-C2-S-S-pyridine / 否
HY-13966S3 2-Deoxy-D-glucose-13C6 / 否
HY-140157 N-Me-N-bis(PEG4-C2-Boc) / 否
HY-14164S1 Zileuton-13C2,15N Inhibitor / 否
HY-144348S N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N / 否
HY-149559 Thalidomide-5-O-C2-NH2 hydrochloride 98.01% 否
HY-150525S Acetyl-1,2 Coenzyme A-13c2 Lithium / 否
HY-15121S1 L-Theanine-13C2,15N2 / 否
HY-152040S Tenuazonic acid-(acetyl-13C2) (mixture of diastereomers) in methanol / 否
HY-156326S (3E,5E)-Octadien-2-one-13C2 / 否
HY-156326S1 (3E,5Z)-Octadien-2-one-13C2 / 否
HY-158080 2-Keto-L-gulonic acid Inhibitor / 否
HY-158343 Thalidomide-NH-PEG2-C2-CH2 / 否
HY-158918 4-CF3-TPP-DC / 否
HY-160069 Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH / 否
HY-160235 Pomalidomide-C2-amide-C5-azide / 否
HY-161773 HL389-NHC2-PEG3-C2NH / 否
HY-164043 (S,R,S)-AHPC(Me)-amido-C2-acid / 否
HY-164391 Pomalidomide-C2-amide-C4-Br / 否
HY-16504S Treprostinil-13C2-d1 Sodium Agonist / 否
HY-165064 C2 L-Erythro ceramide (d18:1/2:0) / 否
HY-165072 C2 3'-Sulfo galactosylceramide (d18:1/2:0) / 否
HY-165691S Chlorothalonil Metabolite R611553-13C2,15N2 sodium salt / 否
HY-165694S 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-13C2,15N2 / 否
HY-165696S 2,4-Dicarbamoyl-3,5,6-trichlorobenzenesulfonate (sodium)-13C2,15N2 / 否
HY-166226 C2 Sphingomyelin (d18:1/2:0) / 否
HY-166896S 2,3,3',4',5,5'-Hexachloro-1,1'-biphenyl-13C12 / 否
HY-168244 TsO-C2-Piperidine-O-azetidine-CO-Ph-C2-OH / 否
HY-168297 Piperidine-C2-Pip-C-COOH / 否
HY-168723 Piperidine-C-Pip-C2-Pip-C2-OH / 否
HY-168870 OH-PEG3-C2-Succinamic acid-2-(Methylamino)ethanol / 否
HY-169480 Lipid C2 / 否
HY-170315 Ethyne-C2-Pip-CO-Pip-Boc / 否
HY-170319 Lenalidomide-ethyne-C2-Pip-CO-Pip / 否
HY-171024 Cannabinol ethyl / 否
HY-176176S MDEKMLVLWVVALS(Gly-13C2,15N)IST / 否
HY-176422 (S,R,S)-AHPC-Amide-PEG2-C2-NH2 / 否
HY-176478 PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC / 否
HY-50719S1 2-Acetyl-1-pyrroline-13C5 / 否
HY-76204S1 Glycine ethyl ester-13C2 hydrochloride / 否
HY-B0031S2 Quetiapine-d8 fumarate / 否
HY-B0084S3 Dienogest-13C2,15N Agonist / 否
HY-B0124S1 Zonisamide-13C2,15N / 否
HY-B0214S3 Prednisone-13C2,d2 / 否
HY-B0554S1 Norethindrone-13C2 Agonist / 否
HY-B0660S1 Eicosapentaenoic acid 1,2,3,4,5-13C5 Activator / 否
HY-B1258S Intermediate of tranexamic Acid-13C2,15N / 否
HY-B1290S3 2-Phenylethanol-13C2 Inhibitor / 否
HY-B1473S1 Serotonin-13C2,15N hydrochloride / 否
HY-B1892S1 Cefazolin-13C2,15N Inhibitor / 否
HY-N0091S4 Hypoxanthine-13C2,15N-1 / 否
HY-N0229S19 L-Alanine-1,2-13C2 / 否
HY-N0230S5 β-Alanine-13C / 否
HY-N0420S3 Butanedioic acid-13C2 ≥99.0% 否
HY-N0420S4 Succinic acid-13C2 / 否
HY-N12156 Ajugasterone C 2-acetate / 否
HY-N14104 Cinatrin C2 Inhibitor / 否
HY-N14431 Salfredin C2 Inhibitor / 否
HY-N14459 Pluracidomycin C2 Inhibitor / 否
HY-N14705 2-Hydroxygentamicin C2 Inhibitor / 否
HY-N14709 Kibdelin C2 Inhibitor / 否
HY-N14844 Napyradiomycin C2 Inhibitor / 否
HY-N15125 1-Deamino-1-hydroxygentamicin C2 Inhibitor / 否
HY-N2362S9 DL-Alanine-13C2,15N / 否
HY-N5199 4"-Demethylgentamicin C2 Inhibitor / 否
HY-N7125S Cinnamyl acetate-13C2 / 否
HY-N7521 Procyanidin C2 / 否
HY-N9484S Menthofuran-13C2 / 否
HY-RS17030 C2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS17438 Cfb Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20653 Sult1c2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS21673 Nt5c2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS22687 Nr2c2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23474 C2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS24021 Akr1c2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27164 Sult1c2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS28191 Nt5c2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS29201 Nr2c2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W001942S2 DL-2-Methylbutyric acid-13C2 / 否
HY-W010392S1 Ethyl 2-methylbutanoate-13C2 / 否
HY-W010489S1 2-Phenylacetaldehyde-13C2 / 否
HY-W011577S1 Dibenzo[a,c]anthracene-13C6 / 否
HY-W012578S1 2-Isopropyl-3-methoxypyrazine-13C3 / 否
HY-W012864S2 (2S,3R)-2,3,4-Trihydroxybutanal-13C-2 99.4% 否
HY-W012932S 2,4-Dimethylthiazole-13C3 / 否
HY-W012998S1 2,3-Pentanedione-13C2 / 否
HY-W015307S 4-Ethyloctanoic acid-13C2 / 否
HY-W015466S1 Acetylvaline-13C2 / 否
HY-W015604S 2,3-Diethyl-5-methylpyrazine-13C2 / 否
HY-W020678S 2-Methylbutanal-13C2 / 否
HY-W097410S1 2-Iodo-N-phenylacetamide-13C6 / 否
HY-W102356S1 Phenethyl acetate-13C2 / 否
HY-W127515S trans-2,cis-6-Nonadienal-13C2 / 否
HY-W343292S 2-Methylbutyl acetate-13C2 / 否
HY-W352408 1,2,3-Tri-α-linolenoyl glycerol / 否
HY-W590664 C2 Dihydroceramide / 否
HY-W615166 Thalidomide-NH-C2-alkyne / 否
HY-W615173 NHS ester-C2-NHCO-C2-NHS / 否
HY-W654191 Fipronil detrifluoromethylsulfinyl-13C2,15N2 / 否
HY-W654304 Oxonic Acid -13C2,15N3 potassium salt hydrate / 否
HY-W654343 D-Erythro-sphingosine-1-phosphate-13C2,d2 / 否
HY-W673588S 2,3-Dichlorobiphenyl-13C12 / 否
HY-W703429S 2,3,6,7-Tetrachloro-naphthalene-13C10 / 否
HY-W715311S 2,2',3,3',4',5,5'-Heptachloro-4-biphenylol-13C12 / 否
HY-W718588S 2,2',3,3',5,5'-Hexachlorobiphenyl-13C12 / 否
HY-W748320 2,2',3,3',4,5,5',6,6'-Nonachloro-1,1'-biphenyl-13C12 / 否
HY-W748321 2,2',3,4',5,6,6'-heptachloro-1,1'-biphenyl-13C12 / 否
HY-W748327 2,5-Dichloro-1,1'-biphenyl-13C12 / 否
HY-W748328 Ixazomib-13C2,15N / 否
HY-W748343 2,2',5,5'-Tetrachloro-1,1'-biphenyl-13C12 / 否
HY-W748345 2,3',4,4',5,5'-Hexachloro-1,1'-biphenyl-13C12 / 否
HY-W748350 2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl-13C12 / 否
HY-W766368 C6 Ceramide-13C2,d2 / 否
HY-W768398 Ethephon-13C2 / 否
HY-W777166 Aprepitant-13C2,d2 (Major) Inhibitor / 否
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / 否
HY-W777702 2,2',3,4',5,5',6-Heptachloro-4-biphenylol-13C12 / 否
HY-W778064 L-threo-Droxidopa-13C2,15N / 否
HY-W778142 Dimethyl Phosphate-13C2 sodium / 否
HY-W778154 O,O-Dimethyl dithiophosphate-13C2 ammonium Inhibitor / 否
HY-W778207 2'-Deoxyadenosine-13C5 monohydrate / 否
HY-W778391 Bisphenol A-13C2 / 否
HY-W779002 alpha-D-glucose-13C2-1 / 否
HY-W779254 Ethanolamine-13C2 / 否
HY-Y0045S 2-Acetylthiazole-13C2 / 否
HY-Y1206S Chloroacetyl chloride-13C2 ≥96.0% 否
HY-B0627S1 Metformin-13C2 hydrochloride / 否
HY-111555 AmPEG6C2-Aur0131 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens C2 NCBI NCBI:717
Canis familiaris C2 NCBI NCBI:474853
Macaca fascicularis C2 NCBI NCBI:102137096
Mus musculus C2 NCBI NCBI:12263
Macaca mulatta C2 NCBI NCBI:106997899
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z